---
title: Cellab CDMO vs eXmoor Pharma
slug_a: cellab
slug_b: exmoorpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cellab/exmoorpharma
---

# Cellab CDMO vs eXmoor Pharma

Side-by-side profile data from each company listing on this directory.

## Cellab CDMO

- Profile: [/companies/cellab](/companies/cellab)

Cellab CDMO — Cell and gene therapy CDMO providing cell banking, GMP manufacturing, cryopreservation and EU QP batch release for clinical-stage ATMPs. Operates a 1,000 m² facility with four Grade B and one Grade C cleanroom plus an AABB-accredited cell bank.

Services: 7. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- Quality Control Testing
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## eXmoor Pharma

- Profile: [/companies/exmoorpharma](/companies/exmoorpharma)

eXmoor Pharma — Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Single-Use / Disposable